
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $737.1M | -- | -- | $0.72 | -- |
07/25/2025 | Q2 | $563.2M | -- | -- | $0.36 | -- |
04/25/2025 | Q1 | $623.4M | $629.8M | $0.43 | $0.52 | -$0.09 |
02/25/2025 | Q4 | $835.8M | $859.7M | $1.71 | $1.92 | -$0.21 |
10/25/2024 | Q3 | $755.6M | $758.5M | $1.62 | $1.40 | $0.22 |
07/26/2024 | Q2 | $568.2M | $564.4M | $0.76 | $0.50 | $0.26 |
04/26/2024 | Q1 | $640.4M | $661.5M | $1.04 | $0.77 | $0.27 |
02/27/2024 | Q4 | $869.1M | $857.9M | $2.90 | $2.61 | $0.29 |
10/27/2023 | Q3 | -- | -- | $1.78 | $1.54 | $0.24 |
07/28/2023 | Q2 | -- | -- | $0.64 | $0.53 | $0.11 |
04/28/2023 | Q1 | -- | -- | $0.95 | $0.57 | $0.38 |
02/24/2023 | Q4 | -- | -- | $2.11 | $1.73 | $0.38 |
10/28/2022 | Q3 | -- | -- | $1.67 | $1.71 | -$0.04 |
07/29/2022 | Q2 | -- | -- | $0.93 | $1.60 | -$0.67 |
04/29/2022 | Q1 | -- | -- | $1.66 | $1.39 | $0.27 |
02/25/2022 | Q4 | -- | -- | $2.31 | $2.05 | $0.26 |
10/29/2021 | Q3 | -- | -- | $1.93 | $1.73 | $0.20 |
07/30/2021 | Q2 | -- | -- | $1.62 | $0.79 | $0.83 |
04/30/2021 | Q1 | -- | -- | $1.96 | $0.32 | $1.64 |
02/26/2021 | Q4 | -- | -- | $2.26 | $2.73 | -$0.47 |
10/23/2020 | Q3 | -- | -- | $1.85 | $1.57 | $0.28 |
07/24/2020 | Q2 | -- | -- | $0.19 | -$0.25 | $0.44 |
05/05/2020 | Q1 | -- | -- | -$1.82 | $0.16 | -$1.98 |
02/24/2020 | Q4 | -- | -- | $2.82 | $2.89 | -$0.07 |
10/24/2019 | Q3 | -- | -- | $1.34 | $1.70 | -$0.36 |
07/25/2019 | Q2 | -- | -- | $0.97 | $0.81 | $0.16 |
04/30/2019 | Q1 | -- | -- | $0.75 | $0.72 | $0.03 |
02/25/2019 | Q4 | -- | -- | $2.83 | -- | -- |
10/25/2018 | Q3 | -- | -- | $1.53 | -- | -- |
07/26/2018 | Q2 | -- | -- | $0.79 | -- | -- |
04/26/2018 | Q1 | -- | -- | $0.89 | -- | -- |
02/27/2018 | Q4 | -- | -- | $2.84 | -- | -- |
10/26/2017 | Q3 | -- | -- | $1.71 | -- | -- |
07/27/2017 | Q2 | -- | -- | $0.77 | -- | -- |
04/27/2017 | Q1 | -- | -- | $0.95 | -- | -- |
02/23/2017 | Q4 | -- | -- | $1.76 | -- | -- |
10/27/2016 | Q3 | -- | -- | $1.60 | -- | -- |
07/27/2016 | Q2 | -- | -- | $0.71 | -- | -- |
04/28/2016 | Q1 | -- | -- | $1.04 | -- | -- |
02/25/2016 | Q4 | -- | -- | $1.39 | -- | -- |
10/29/2015 | Q3 | -- | -- | $1.51 | -- | -- |
Carter's reported $629.8M worth of top line sales in its most recent quarter.
Carter's announced earnings per share of $0.43 which represents a miss of analyst forecast a $0.52 per share.
Carter's reported $291.1M that represents $8.24 per share over the last quarter.
Carter's's earnings are forecast to decrease from $5.12 per share to $5.22 per share next year representing a decrease of -33.53%.
Carter's's next earnings date is July 25, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.